China Daily (Hong Kong)

BIG IMPROVEMEN­T

Fosun head sees limited trade tension impact

- By LUO WEITENG in Hong Kong sophia@chinadaily­hk.com

Although escalating trade tensions between the world’s two largest economies have dimmed the global economic growth outlook, China will continue to move forward thanks to hardworkin­g common people and private companies, said one of China’s richest men and most active global dealmakers.

“The fundamenta­l driving force for China’s economic growth comes from the burning desire and unremittin­g efforts of the country’s ordinary people and private enterprise­s to improve their lives,” said Guo Guangchang, executive director and chairman of Fosun Internatio­nal Ltd, one of the largest private conglomera­tes on mainland.

“For China, the core issue under the shadow of the Sino-US trade skirmish is solving our own problems at home. China’s economic developmen­t will not be stymied, which comes on the premise that we stick to and press ahead with the path of opening markets and other reforms that has lifted growth,” Guo said.

He made the remarks at the company’s interim results conference held in Hong Kong on Wednesday.

The Hong Kong-listed company booked net profit of 6.86 billion yuan ($1.01 billion) for the six months ended in June, up 17 percent year-on-year, it said in a filing to the Hong Kong stock exchange on Tuesday.

Revenue jumped 20 percent year-on-year to 43.51 billion yuan during the same period.

From humble beginnings in pharmaceut­icals and property developmen­t, the Shanghai-based company has today built up a business empire that spans diverse fields, including pharmaceut­icals and healthcare, tourism, culture and fashion, as well as insurance and financial services.

Riding high on its expanding global footprint, the company has turned its eyes from Europe and the United States to more populous and less developed markets, including India, Indonesia and countries in Africa, said Xu Xiaoliang, co-president of Fosun. Its new target countries mirror China’s past, years or even decades ago, and count on their demographi­c dividends to emulate China’s developmen­t miracle, Xu said.

In the first half of the year, Fosun invested 4 billion yuan into technologi­es and innovation­s, aiming to meet the pledge it made in March to pour more than 20 billion yuan into cutting-edge technologi­es over the coming three years. The move is part of the acquisitiv­e company’s goal to lead the way to the next big tech breakthrou­gh, and build up an investment empire of billion-dollar companies.

Babytree, a mobile app for young or expecting mothers, is just one unicorn — a startup valued at $1 billion or more — in which Fosun owns a substantia­l stake. It filed for an IPO in Hong Kong in June.

The move underscore­s Fosun’s push to capitalize on the financial center’s appetite for tech floats, as it puts more high-quality assets from its investment portfolio on an IPO trajectory.

Fosun has also received approval from the Hong Kong stock exchange to spin off its tourism and hotel unit, which includes Club Med, in July, and aims to list the unit.

Shares of Fosun Internatio­nal edged up 0.14 percent to close at HK$14.56 ($1.85) on Wednesday. The benchmark Hang Seng Index rose 0.23 percent, or 64.82 points, to finish at 28416.44 points.

 ?? PROVIDED TO CHINA DAILY ?? A Fosun Pharma employee addresses queries from visitors at a medical exhibition in Shanghai.
PROVIDED TO CHINA DAILY A Fosun Pharma employee addresses queries from visitors at a medical exhibition in Shanghai.

Newspapers in English

Newspapers from China